Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coronin-1A (CORO1A) is an **actin-binding WD repeat protein** crucial for regulating the dynamics and organization of the **actin cytoskeleton** in immune cells, including T cells, neutrophils, macrophages, and natural killer cells[1][2][3]. Coronin-1A aids in processes like **phagocytosis**, immune cell migration, and the assembly and activation of the **NADPH oxidase complex**, notably by interacting with and modulating Arp2/3 complex and small GTPases like Rac, thereby facilitating efficient **reactive oxygen species (ROS)** production essential for pathogen clearance[2][3]. It plays a prominent role in regulating immune responses—deficiency in coronin-1A is linked to severe **immunodeficiency syndromes** in humans, characterized by defective T cell survival, impaired phagocyte function, and susceptibility to certain infections[1][2]. While it is not an established direct therapeutic drug target (e.g., no approved drugs acting on CORO1A), it is an important **biological regulator and biomarker** in immunology and cytoskeletal research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coronin-1A (CORO1A).